UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000011671
Receipt number	R000013646
Scientific Title	Phase I/II study eribulin mesylate and lapatinib for metastatic in patients with human epidermal growth factor receptor 2-positive breast cancer previously treated with an anthracycline, taxane and trastuzumab
Date of disclosure of the study information	2013/09/06
Last modified on	2013/09/06 16:52:15

---